Assessing the ability of cardiovascular disease risk calculators to evaluate effectiveness of trials and interventions

References

• American Heart Association. Heart Disease and Stroke Satistics: 2003 update. TX, USA: American Heart Association (2002).
   Google Scholar
• Sellers DE, Crawford SL, Bullock K, McKinlay JB. Understanding the variability in the effectiveness of community heart health programs: a meta-analysis. Soc. Sci. Med.44(9), 1325–1339 (1997).
   Google Scholar
• Weinehall L, Lewis C, Nafziger AN et al. Different outcomes for different interventions with different focus! A cross-country comparison of community interventions in rural Swedish and US populations. Scand. J. Public Health29(suppl. 56), 46–58 (2001).
   Google Scholar
• Gomel MK, Olderburg B, Simpson JM, Chilvers M, Owen N. Composite cardiovascular risk outcomes of a worksite intervention trial. Am. J. Public Health87(4), 673–676 (1997).
   PubMed Web of Science ®Google Scholar
• Finkelstein EA, Wittenborn JS, Farris RP. Evaluation of public health demonstration programs: the effectiveness and cost-effectiveness of WISEWOMAN. J. Womens Health13(5), 625–633 (2004).
   Google Scholar
• Finkelstein EA, Troped PJ, Will JC, Palombo R. Cost–effectiveness of a cardiovascular disease risk reduction program aimed at financially vulnerable women: the Massachusetts WISEWOMAN project. J. Womens Health Gend. Based Med.6, 519–526 (2002).
   Google Scholar
• Will JC, Massoudi B, Mokdad A et al. Reducing risk for cardiovascular disease in uninsured women: combined results from two WISEWOMAN projects. J. Am. Med. Women’s Assoc.56(4), 161–165 (2001).
   Google Scholar
• Winkleby MA, Feldman HA, Murray DM. Joint analysis of three US community intervention trials for reduction of cardiovascular disease risk. J. Clin. Epidemiol.50(6), 645–658 (1997).
   PubMedGoogle Scholar
• Simpson SH, Johnson JA, Tsuyuki RT. Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists. Pharmacotherapy21(5), 627–635 (2001).
   PubMed Web of Science ®Google Scholar
• Grieve R, Hutton J, Green C. Selecting methods for the prediction of future events in cost–effectiveness models: a decision-framework and example from the cardiovascular field. Health Policy64, 311–324 (2003).
   Google Scholar
• Leaverton PE, Sorlie PD, Kleinman JC et al. Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J. Chronic Dis.40(8), 775–784 (1987).
   PubMedGoogle Scholar
• Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk-factor categories. Circulation97(18), 1837–1847 (1998).
   PubMed Web of Science ®Google Scholar
• Will JC, Farris RP, Sanders CG, Stockmyer CK, Finkelstein EA. Health promotion interventions for disadvantaged women: overview of the WISEWOMAN Projects. J. Womens Health13(5), 484–502 (2004).
   PubMed Web of Science ®Google Scholar
• Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple risk–factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation100(13), 1481–1492 (1999).
   PubMed Web of Science ®Google Scholar
• Wallis EJ, Ramsay LE, Ul Haq I et al. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population. Br. Med. J.320(7236), 671–676 (2000).
   PubMed Web of Science ®Google Scholar
• Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation83(1), 356–362 (1991).
   PubMed Web of Science ®Google Scholar
• Joint British recommendations on prevention of coronary disease in clinical practice: summary. British Cardiac Society, British Hyperlipidemia Association, British Hypertension Society, British Diabetic Association. Br. Med. J.320(7236), 705–708 (2000).
   PubMed Web of Science ®Google Scholar
• Jackson R. Updated New Zealand cardiovascular disease risk–benefit prediction guide. Br. Med. J.320(7236), 709–710 (2000).
   PubMed Web of Science ®Google Scholar
• Conroy RM, Pyorala K, Fitzgerald AP et al. SCORE project group. Estimation of 10 year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart J.24(11), 987–1003 (2003).
   PubMed Web of Science ®Google Scholar
• Avins AL, Browner WS. Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels: what a difference a decade makes. JAMA279(6), 445–449 (1998).
   PubMed Web of Science ®Google Scholar
• Haq IU, Ramsay LE, Jackson PR, Wallis EJ. Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods. QJM92(7), 379–385 (1999).
   Google Scholar
• Reynolds TM, Twomey P, Wierzbicki AS. Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetes. J. Cardiovasc. Risk9(4), 183–190 (2002).
   PubMedGoogle Scholar
• Reynolds TM, Twomey P, Wierzbicki AS. Concordance evaluation of coronary risk scores: implications for cardiovascular risk screening. Curr. Med. Res. Opin.20(6), 811–818 (2004).
   PubMed Web of Science ®Google Scholar
• Wierzbicki AS, Reynolds TM, Gill K, Alg S, Crook MA. A comparison of algorithms for initiation of lipid lowering therapy in primary prevention of coronary heart disease. J. Cardiovasc. Risk7(1), 63–67 (2000).
   Google Scholar
• Quaglini S, Stefanelli M, Boiocchi L, Campari F, Cavallini A, Micieli G. Cardiovascular risk calculators: understanding differences and realising economic implications. Int. J. Med. Inform.74(2–4), 191–199 (2005).
   Google Scholar
• D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA286(2), 180–187 (2001).
   PubMed Web of Science ®Google Scholar
• Liao Y, McGee DL, Cooper RS. Prediction of coronary heart disease mortality in blacks and whites: pooled data from two national cohorts. Am. J. Cardiol.84(1), 31–36 (1999).
   Google Scholar
• Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10 year follow-up of the PROspective CArdiovascular Munster (PROCAM) study. Circulation105(3), 310–315 (2002).
   PubMed Web of Science ®Google Scholar
• D’Agostino RB, Russell MW, Huse DM et al. Primary and subsequent coronary risk appraisal: new results from the Framingham Study. Am. Heart J.143(1), 21 (2002).
   Google Scholar
• Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents and adults, 1999–2002. JAMA.291(23), 2847–2850 (2004).
   PubMed Web of Science ®Google Scholar
• Prentice AM. The emerging epidemic of obesity in developing countries. Int. J. Epidemiol.35(1), 93–99 (2005).
   Google Scholar
• Swan G. Findings from the latest National Diet and Nutrition Survey. Proc. Nutr. Soc.63(4), 505–512 (2004).
   Google Scholar